{"Q": 1, "answer": "no", "rationale": "The segment describes preventative measures (vaccine), not an intensifier directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17508", "batch_size": 260, "batch_pos": 243, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, superlative + negative noun, or critical alert phrase.", "method": "llm_batch", "batch_id": "batch_2_6352", "batch_size": 260, "batch_pos": 221, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The segment describes securing vaccines, not impact using a moderate verb + scale.", "method": "llm_batch", "batch_id": "batch_3_2264", "batch_size": 260, "batch_pos": 199, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_13712", "batch_size": 260, "batch_pos": 185, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports deal details but contains no explicit calming language or keywords.", "method": "llm_batch", "batch_id": "batch_5_17252", "batch_size": 260, "batch_pos": 184, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_14324", "batch_size": 260, "batch_pos": 164, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_13384", "batch_size": 260, "batch_pos": 161, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing doses and an option for more, preparedness/capability, without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_16672", "batch_size": 260, "batch_pos": 70, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
